• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

从过敏级联到上皮细胞驱动的疾病：支气管哮喘的漫长道路。

From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma.

机构信息

Servei de Pneumologia, Hospital Parc Taulí de Sabadell, 08208 Sabadell, Spain.

Departament de Medicina, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.

出版信息

Int J Mol Sci. 2023 Feb 1;24(3):2716. doi: 10.3390/ijms24032716.

DOI:10.3390/ijms24032716
PMID:36769038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917117/
Abstract

In medicine, much of the progress made is due to the emergence of new drugs [...].

摘要

在医学领域，取得的许多进展都归功于新药的出现[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d0/9917117/4704c399e5d1/ijms-24-02716-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d0/9917117/4704c399e5d1/ijms-24-02716-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d0/9917117/4704c399e5d1/ijms-24-02716-g0A1.jpg

相似文献

1
From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma.从过敏级联到上皮细胞驱动的疾病：支气管哮喘的漫长道路。
Int J Mol Sci. 2023 Feb 1;24(3):2716. doi: 10.3390/ijms24032716.
2
High probability of comorbidities in bronchial asthma in Germany.德国支气管哮喘的合并症发生概率较高。
NPJ Prim Care Respir Med. 2017 Apr 21;27(1):28. doi: 10.1038/s41533-017-0026-x.
3
[Relationship between bronchial hypersensitivity and hereditary factors in respiratory tract allergic diseases: bronchial asthma and nasal allergy].呼吸道过敏性疾病中支气管高反应性与遗传因素的关系：支气管哮喘和鼻过敏
Arerugi. 1990 May;39(5):465-75.
4
[Bronchial asthma: progress in diagnosis and treatments. Topics: II. Pathogenesis and pathophysiology: 3. Roles of airway epithelium on the pathogenesis of allergic airway inflammation].
Nihon Naika Gakkai Zasshi. 2013 Jun 10;102(6):1370-7. doi: 10.2169/naika.102.1370.
5
Bronchoscopy-guided bronchial epithelium sampling as a tool for selecting the optimal biologic treatment in a patient with severe asthma: a case report.支气管镜引导下支气管上皮采样作为选择重度哮喘患者最佳生物治疗方法的工具：病例报告
Allergy Asthma Clin Immunol. 2019 Nov 27;15:76. doi: 10.1186/s13223-019-0378-6. eCollection 2019.
6
IL-23 secreted by bronchial epithelial cells contributes to allergic sensitization in asthma model: role of IL-23 secreted by bronchial epithelial cells.支气管上皮细胞分泌的白细胞介素-23在哮喘模型中促进变应性致敏：支气管上皮细胞分泌的白细胞介素-23的作用
Am J Physiol Lung Cell Mol Physiol. 2017 Jan 1;312(1):L13-L21. doi: 10.1152/ajplung.00114.2016. Epub 2016 Nov 18.
7
Allergic bronchial asthma and rhinitis; the importance of studies for sensitivity to foods.过敏性支气管哮喘和鼻炎；食物敏感性研究的重要性。
Calif Med. 1956 Jul;85(1):33-5.
8
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats.角质形成细胞生长因子可改善变应性大鼠的肺通透性及支气管上皮改变。
Eur Respir J. 2007 Jul;30(1):31-9. doi: 10.1183/09031936.00011606. Epub 2007 Mar 28.
9
[Allergic comorbidities in bronchial asthma, in children].[儿童支气管哮喘中的变应性共病]
Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):633-7.
10
Novel treatments of asthma and allergic diseases.哮喘和过敏性疾病的新型治疗方法。
Paediatr Respir Rev. 2014 Dec;15(4):355-62. doi: 10.1016/j.prrv.2013.10.007. Epub 2013 Nov 5.

引用本文的文献

1
Upregulated Hexokinase-2 in Airway Epithelium Regulates Apoptosis and Drives Inflammation in Asthma via Peptidylprolyl Isomerase F.气道上皮中上调的己糖激酶-2通过肽基脯氨酰异构酶F调节细胞凋亡并引发哮喘炎症。
Cells. 2025 Jul 1;14(13):1004. doi: 10.3390/cells14131004.
2
The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.IgE在哮喘气道上皮中的直接和间接作用
Allergy. 2025 Apr;80(4):919-931. doi: 10.1111/all.16459. Epub 2025 Feb 18.
3
The Incredible Adventure of Omalizumab.奥马珠单抗的奇妙历程

本文引用的文献

1
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.NAVIGATOR：一项 3 期多中心、随机、双盲、安慰剂对照、平行分组试验，旨在评估特泽泊鲁单抗在成人和青少年中重度、未控制的哮喘中的疗效和安全性。
Respir Res. 2020 Oct 13;21(1):266. doi: 10.1186/s12931-020-01526-6.
2
Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.新单克隆抗体治疗严重哮喘的重叠作用。
Drugs. 2017 Oct;77(16):1769-1787. doi: 10.1007/s40265-017-0810-5.
3
dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
Int J Mol Sci. 2024 Mar 6;25(5):3056. doi: 10.3390/ijms25053056.
发散性：IgE轴如何促成过敏性哮喘的连续过程及抗IgE疗法
Int J Mol Sci. 2017 Jun 21;18(6):1328. doi: 10.3390/ijms18061328.
4
Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study.奥马珠单抗对季节性或常年性过敏原引起的持续性过敏性口服糖皮质激素依赖型哮喘同样有效：一项试点研究。
Int J Mol Sci. 2017 Feb 28;18(3):521. doi: 10.3390/ijms18030521.
5
Omalizumab for severe asthma: efficacy beyond the atopic patient?奥马珠单抗治疗严重哮喘：非变应性患者的疗效如何？
Drugs. 2014 Apr;74(5):521-33. doi: 10.1007/s40265-014-0203-y.
6
The relevance of IgE in the pathogenesis of allergy: the effect of an anti-IgE drug in asthma and other diseases.
Recent Pat Inflamm Allergy Drug Discov. 2007 Jun;1(2):151-64. doi: 10.2174/187221307780979865.